Segment & Geographic Data
Quant-Grade Normalized Data
API & CSV Delivery
Taro Pharmaceutical Industries Ltd's Business Segments
Taro Pharmaceutical Industries Ltd's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Reportable Segments
-
Largest Segment
-
Total Revenue
-
Regions Reported
3
Annual Results
Revenue Share by Country -
- United States63.4%
- Canada23.8%
- Israel8.1%
Revenue by Geographic Country -
| Country | Revenue (Millions) | % of Total |
|---|---|---|
| United States | $ 363 | 63.4% |
| Canada | $ 136 | 23.8% |
| Israel | $ 46 | 8.1% |
Revenue by Product & Service Category -
- Royalty0%
Revenue by Product & Service Category -
| Category | Revenue (Millions) | % of Total |
|---|---|---|
| Royalty | - | 0% |
Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.
Description of Taro Pharmaceutical Industries Ltd
Taro Pharmaceutical Industries Ltd is a leading global pharmaceutical company that develops, manufactures, and markets prescription and over-the-counter (OTC) drugs for a range of therapeutic areas. Headquartered in Haifa Bay, Israel, Taro has a presence in more than 25 countries across North America, Europe, and Asia-Pacific. Established in 1950, the company has grown to become one of the top 10 generic drug manufacturers in the world.
Taro has a diverse portfolio of products that includes a wide range of topical creams, ointments, and gels; inhalers; tablets and capsules; liquids and pellets; and suspensions. The company's product portfolio spans multiple therapeutic categories, including dermatology, cardiology, gastroenterology, oncology, pediatrics, and urology. Some of its leading products include generic versions of Lotemax (loteprednol etabonate ophthalmic suspension), Ketoconazole Cream 2%, and the Lidocaine Patch 5%.
One of Taro's key strengths is its ability to deliver high-quality, affordable generics to customers around the world. The company has a state-of-the-art manufacturing infrastructure, which includes multiple research and development centers, manufacturing plants, and distribution centers. Taro's manufacturing facilities are located in Israel, Canada, and India, and are equipped with the latest technologies and processes to ensure high quality and efficiency. Its research and development centers are focused on developing new products and enhancing existing ones.
Taro's commitment to quality is reflected in its adherence to strict regulatory standards. The company has several regulatory approvals from the US FDA, Health Canada, and other regulatory agencies around the world. Taro's products are known for their efficacy, safety, and reliability, which has earned the company an enviable reputation in the global pharmaceutical industry.
Taro's success is also attributed to its strong corporate culture that is based on innovation, collaboration, and ethical practices. The company places a high value on its employees and invests in their development and wellbeing. Taro is committed to creating a diverse and inclusive work environment that fosters growth, innovation, and productivity. The company's ethical practices are reflected in its commitment to adhering to strict compliance standards and ensuring the safety and wellbeing of its patients and customers.
In summary, Taro Pharmaceutical Industries Ltd is a leading global pharmaceutical company that delivers high-quality, affordable generics to customers around the world. The company has a diverse portfolio of products, a state-of-the-art manufacturing infrastructure, and a strong commitment to quality, innovation, and ethical practices. Its continued growth and success in the global pharmaceutical industry are a testament to its unwavering commitment to excellence.
Taro has a diverse portfolio of products that includes a wide range of topical creams, ointments, and gels; inhalers; tablets and capsules; liquids and pellets; and suspensions. The company's product portfolio spans multiple therapeutic categories, including dermatology, cardiology, gastroenterology, oncology, pediatrics, and urology. Some of its leading products include generic versions of Lotemax (loteprednol etabonate ophthalmic suspension), Ketoconazole Cream 2%, and the Lidocaine Patch 5%.
One of Taro's key strengths is its ability to deliver high-quality, affordable generics to customers around the world. The company has a state-of-the-art manufacturing infrastructure, which includes multiple research and development centers, manufacturing plants, and distribution centers. Taro's manufacturing facilities are located in Israel, Canada, and India, and are equipped with the latest technologies and processes to ensure high quality and efficiency. Its research and development centers are focused on developing new products and enhancing existing ones.
Taro's commitment to quality is reflected in its adherence to strict regulatory standards. The company has several regulatory approvals from the US FDA, Health Canada, and other regulatory agencies around the world. Taro's products are known for their efficacy, safety, and reliability, which has earned the company an enviable reputation in the global pharmaceutical industry.
Taro's success is also attributed to its strong corporate culture that is based on innovation, collaboration, and ethical practices. The company places a high value on its employees and invests in their development and wellbeing. Taro is committed to creating a diverse and inclusive work environment that fosters growth, innovation, and productivity. The company's ethical practices are reflected in its commitment to adhering to strict compliance standards and ensuring the safety and wellbeing of its patients and customers.
In summary, Taro Pharmaceutical Industries Ltd is a leading global pharmaceutical company that delivers high-quality, affordable generics to customers around the world. The company has a diverse portfolio of products, a state-of-the-art manufacturing infrastructure, and a strong commitment to quality, innovation, and ethical practices. Its continued growth and success in the global pharmaceutical industry are a testament to its unwavering commitment to excellence.
Taro Pharmaceutical Industries Ltd is a prominent player in the global pharmaceutical landscape, known for its extensive portfolio of products and services that are strategically segmented to address various healthcare needs. Below is an extensive description of the key segments offered by Taro:
1. Prescription Products
Taros prescription product line is comprehensive, encompassing a wide range of therapeutic categories aimed at treating numerous medical conditions. The offerings include:
- Antibiotics: A selection of medications designed to combat bacterial infections through various mechanisms of action.
- Anti-Inflammatory Drugs: These products help reduce inflammation and alleviate pain associated with conditions like arthritis and other inflammatory disorders.
- Antiviral Medications: Taro produces antiviral drugs that target viral infections, helping to manage and treat diseases caused by viruses.
- Antifungal Agents: A range of antifungal products is available to treat fungal infections affecting various body systems.
- Oncology Products: Taro provides medications aimed at combating cancer, including chemotherapeutic agents and supportive care products.
- Cardiovascular Medications: Productos designed to manage heart conditions, hypertension, and other cardiovascular issues are part of Taros offerings.
- Pain Management: Taro includes a variety of pain relief medications for acute and chronic pain management.
Over-the-Counter (OTC) Products
Taro has developed a diverse selection of over-the-counter products that offer consumers accessible healthcare solutions without the need for a prescription. This category includes:
- Vitamins and Dietary Supplements: A broad range of nutritional supplements targeting various health concerns and promoting overall well-being.
- Pain Relievers: Non-prescription pain management options, including acetaminophen and ibuprofen-based products.
- Cough and Cold Medications: Formulations designed to alleviate symptoms of colds and flu, providing relief from cough, fever, and nasal congestion.
- Anti-Itch Creams: Topical products addressing skin irritations and allergic reactions, providing prompt relief from itching.
- Skin Care Products: A variety of formulations aimed at treating skin conditions, including moisturizers, ointments, and medicated creams.
Active Pharmaceutical Ingredients (APIs)
Taro is also a significant player in the Active Pharmaceutical Ingredients market, which involves:
- Manufacturing and Supply: Taro manufactures high-quality APIs used by other pharmaceutical companies globally. Their production processes adhere to stringent quality standards.
- Diverse API Portfolio: The company provides a range of APIs essential for the development of various therapeutic drugs, including antibiotics, antifungals, antihypertensives, and antineoplastics.
Contract Manufacturing
Taro Pharmaceutical Industries offers contract manufacturing services, providing:
- Formulation Development: Tailored solutions for pharmaceutical companies looking to develop new formulations or enhance existing ones.
- Manufacturing Services: High-quality manufacturing capabilities across a range of dosage forms, ensuring compliance with regulatory requirements.
- Packaging Solutions: Comprehensive packaging services to ensure the products are safely and effectively delivered to the market.
Generics
Taro has a robust line of generic pharmaceuticals, characterized by:
- Wide Range of Products: The company markets and distributes an extensive array of generic drugs across various therapeutic categories.
- Development Pipeline: Taro is committed to continual innovation, with an extensive pipeline of generic drugs in development, ensuring a steady flow of high-quality generic options for healthcare providers and patients alike.
Conclusion
Taro Pharmaceutical Industries Ltd is renowned for its commitment to providing a diverse spectrum of pharmaceutical products and services that are meticulously designed to meet the varied needs of the global healthcare community. With a stringent focus on quality and innovation, Taro’s products are trusted by healthcare professionals worldwide. The companys multifaceted approach, encompassing prescription drugs, OTC products, APIs, contract manufacturing, and generics, underscores its role as a key contributor to the pharmaceutical industry.
1. Prescription Products
Taros prescription product line is comprehensive, encompassing a wide range of therapeutic categories aimed at treating numerous medical conditions. The offerings include:
- Antibiotics: A selection of medications designed to combat bacterial infections through various mechanisms of action.
- Anti-Inflammatory Drugs: These products help reduce inflammation and alleviate pain associated with conditions like arthritis and other inflammatory disorders.
- Antiviral Medications: Taro produces antiviral drugs that target viral infections, helping to manage and treat diseases caused by viruses.
- Antifungal Agents: A range of antifungal products is available to treat fungal infections affecting various body systems.
- Oncology Products: Taro provides medications aimed at combating cancer, including chemotherapeutic agents and supportive care products.
- Cardiovascular Medications: Productos designed to manage heart conditions, hypertension, and other cardiovascular issues are part of Taros offerings.
- Pain Management: Taro includes a variety of pain relief medications for acute and chronic pain management.
Over-the-Counter (OTC) Products
Taro has developed a diverse selection of over-the-counter products that offer consumers accessible healthcare solutions without the need for a prescription. This category includes:
- Vitamins and Dietary Supplements: A broad range of nutritional supplements targeting various health concerns and promoting overall well-being.
- Pain Relievers: Non-prescription pain management options, including acetaminophen and ibuprofen-based products.
- Cough and Cold Medications: Formulations designed to alleviate symptoms of colds and flu, providing relief from cough, fever, and nasal congestion.
- Anti-Itch Creams: Topical products addressing skin irritations and allergic reactions, providing prompt relief from itching.
- Skin Care Products: A variety of formulations aimed at treating skin conditions, including moisturizers, ointments, and medicated creams.
Active Pharmaceutical Ingredients (APIs)
Taro is also a significant player in the Active Pharmaceutical Ingredients market, which involves:
- Manufacturing and Supply: Taro manufactures high-quality APIs used by other pharmaceutical companies globally. Their production processes adhere to stringent quality standards.
- Diverse API Portfolio: The company provides a range of APIs essential for the development of various therapeutic drugs, including antibiotics, antifungals, antihypertensives, and antineoplastics.
Contract Manufacturing
Taro Pharmaceutical Industries offers contract manufacturing services, providing:
- Formulation Development: Tailored solutions for pharmaceutical companies looking to develop new formulations or enhance existing ones.
- Manufacturing Services: High-quality manufacturing capabilities across a range of dosage forms, ensuring compliance with regulatory requirements.
- Packaging Solutions: Comprehensive packaging services to ensure the products are safely and effectively delivered to the market.
Generics
Taro has a robust line of generic pharmaceuticals, characterized by:
- Wide Range of Products: The company markets and distributes an extensive array of generic drugs across various therapeutic categories.
- Development Pipeline: Taro is committed to continual innovation, with an extensive pipeline of generic drugs in development, ensuring a steady flow of high-quality generic options for healthcare providers and patients alike.
Conclusion
Taro Pharmaceutical Industries Ltd is renowned for its commitment to providing a diverse spectrum of pharmaceutical products and services that are meticulously designed to meet the varied needs of the global healthcare community. With a stringent focus on quality and innovation, Taro’s products are trusted by healthcare professionals worldwide. The companys multifaceted approach, encompassing prescription drugs, OTC products, APIs, contract manufacturing, and generics, underscores its role as a key contributor to the pharmaceutical industry.